Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 3
Submit an article Journal homepage
4,169
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Use of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphoma

Hoa Van Lea Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, NJ, USAView further author information
,
Kim Van Naarden Braunb Translational Epidemiology, Bristol Myers Squibb, Princeton, NJ, USACorrespondence[email protected]
View further author information
,
Grzegorz S. Nowakowskic Hematology, Mayo Clinic, Rochester, MN, USAView further author information
,
David Sermerd Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAORCID Iconhttps://orcid.org/0000-0003-0528-7728View further author information
ORCID Icon,
John Radforde Department of Medical Oncology, The Christie NHS Foundation Trust and University of Manchester, Manchester Academic Health Science Centre, Manchester, UKView further author information
,
William Townsendf Hematology, University College London Hospitals NHS Foundation Trust, London, UKView further author information
,
Herve Ghesquieresg Department of Hematology, Hôpital Lyon Sud, Lyon, FranceORCID Iconhttps://orcid.org/0000-0002-3131-3718View further author information
ORCID Icon,
Tobias Menneh Hematology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Northumberland, UKView further author information
,
Edit Porpaczyi Comprehensive Cancer Center, Medical University of Vienna, Vienna, AustriaView further author information
,
Christopher P. Foxj Department of Clinical Hematology, Nottingham University Hospitals NHS Trust, Nottingham, UKView further author information
,
Claudia Schusterbauerk Clinical Research and Development, Celgene, a Bristol-Myers Squibb Company, Boudry, SwitzerlandView further author information
,
Fei Fei Liul Worldwide Health Economics and Outcomes Research CAR T, Bristol Myers Squibb, Princeton, NJ, USAView further author information
,
Lihua Yuem Statistics, Bristol Myers Squibb, Princeton, NJ, USAView further author information
,
Marc De Benedettia Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, NJ, USAView further author information
&
Jens Hasskarln Cell Therapy Development, Celgene, a Bristol-Myers Squibb Company, Boudry, SwitzerlandView further author information
 show all
Pages 573-585 | Received 08 Jul 2022, Accepted 08 Dec 2022, Published online: 08 Feb 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.